tuhurabio.com - Bathi operasional EBITDA HURA
TuHURA Biosciences, Inc. (HURA) bases its development of targeted cancer immunotherapy on external financing due to a lack of current sales. Geopolitical instability complicates international trials and reagent supplies, a trend captured by the EBITDA dynamics displayed in this chart from GURU.Markets, where the 0.00 level reflects the current state. The issuer's future revenues rely on the rollout of innovative vaccines for insurance companies.
TuHURA Biosciences Inc. - rincian analitis lan metrik utama (HURA)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang Agregat marang Modal TuHURA Biosciences, Inc.|HURA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal TuHURA|HURA - Gunggung utang perusahaan|Rasio utang marang aset resik TuHURA|HURA - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan TuHURA Biosciences|Rasio jangkoan perantara tuhurabio.com
- statistik bathi lan rasio pasar:
HURA - Bathi resik|Proyeksi bathi mangsa ngarep TuHURA Biosciences, Inc.|HURA - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi TuHURA|HURA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan TuHURA Biosciences, Inc.|HURA - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan TuHURA Biosciences|HURA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan tuhurabio.com|HURA - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep TuHURA Biosciences, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:TuHURA Biosciences Inc.
This indicator measures actual cash inflow from core operations, stripping the financial result of non-cash GAAP adjustments to reveal true operational efficiency. Analysis based on aggregated EBITDA allows for tracking the actual liquidity of TuHURA Biosciences (HURA), which is critical given the full outsourcing of manufacturing and clinical trials that eliminates capital expenditures for proprietary facilities.
Analisis pesaing TuHURA Biosciences, Inc.
Bathi operasional EBITDA beigene.com ONC|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Corp - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen Pharma Ltd) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Therapeutics Inc. BCAX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Personalis, Inc. (PSNL)|ERAS - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA DCTH (delcath.com)|Bathi operasional sadurunge potongan amortisasi Y-mAbs Corp|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CADL (candeltx.com) - Bathi operasional sadurunge amortisasi|ARAY (accuray.com) - Bathi operasional sadurunge ngurangi amortisasi|SELLAS Life Sciences Group Inc. (SLS) - Bathi operasional EBITDA|ACTU (Actuate Therapeutics Inc.) - Bathi operasional EBITDA|Bathi operasional EBITDA Citius Oncology Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Protara Therapeutics (TARA)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi FATE|Bathi operasional EBITDA WHWK (aadibio.com)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TCRX (TScan)|CSBR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XBIT (XBiotech Inc)|cel-sci.com (CVM) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi OSTX (OS Therapies Incorporated)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Radiopharm Theranostics Ltd|Bathi sadurunge bunga, pajak, lan amortisasi Artiva Biotherapeutics ARTV|Bathi operasional EBITDA ANL|VERU - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Therapeutics TPST|xiliotx.com (XLO) - Bathi sadurunge bunga, pajak, lan amortisasi|RENB: Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge potongan amortisasi Mural Oncology PLC (MURA)|KAPA (Kairos Pharma Inc) - Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi OnKure Therapeutics Inc (OKUR)|GDTC (CytoMed Therapeutics Ltd) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Curis, Inc. (CRIS)|Bathi operasional EBITDA APLM|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi THAR|Bathi operasional EBITDA ADVB (advanbiomed.com)|GNPX - Bathi operasional sadurunge ngurangi amortisasi|CLDI: Bathi operasional sadurunge ngurangi amortisasi|SBFM - Bathi operasional EBITDA|Xenetic Biosciences (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|PPBT (Purple Biotech Ltd) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi American Oncology Network, Inc. AONC|Bathi operasional EBITDA BGNE|Pendapatan operasional sadurunge ngurangi amortisasi Checkpoint Therapeutics|Elevation Oncology, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA iCAD, Inc. ICAD|Ikena Oncology, Inc. - Bathi operasional EBITDA|NTBL - Bathi operasional EBITDA|VIRX (Viracta Therapeutics) - Bathi operasional sadurunge ngurangi amortisasi|MorphoSys AG - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|NAYA (NAYA Biosciences Corp) - Bathi operasional EBITDA|Bathi operasional EBITDA Ascentage Pharma Group International
